Merck and Moderna's cancer vaccine reduces the risk of death by about half, according to mid-stage trial data released Thursday.
Share:
More In Science
Confidence in Science Fell in 2022 While Political Divides Persisted, Poll Shows
Confidence in the scientific community declined among U.S. adults in 2022, a major survey shows, driven by a partisan divide in views of both science and medicine that emerged during the COVID-19 pandemic.
Cancer Patients Face Shortage of Chemotherapy Drugs
The American Cancer Society estimates that over 20,000 new cancer cases in Connecticut this year alone. But there's a concerning shortage of chemotherapy drugs in the state and across the country. News 12 reporter Mark Sudol tells us why and what can be done.
Jury: PacifiCorp Must Pay Punitive Damages for Wildfires, Plus Award That Could Reach Billions
A jury in Oregon says the electric utility PacifiCorp must pay punitive damages for causing devastating wildfires in 2020 — on top of an earlier verdict already expected to amount to billions of dollars.
Pfizer Warns Shortage Looms for Antibiotic Used to Treat Syphilis
Pfizer is warning that an antibiotic used to treat syphilis and other bacterial infections in young people are likely to run out by the end of this quarter.
Be Well: Alex Rodriguez on the Importance of Dental Hygiene Following Gum Disease Diagnosis
Be Well: Alex Rodriguez on the Importance of Dental Hygiene Following Gum Disease Diagnosis
Be Well: Key Stretches to Consider Before Your Workout
Be Well: Key Stretches to Consider Before Your Workout
Researcher Argues Emojis Could Help Doctors and Patients Communicate
A scientist at the University of California, Riverside is designing an emoji-based measurement system to aid communication between patients and doctors, arguing they could be particularly useful for patients who cannot speak.
Thousands of Dead Fish Wash Up On Texas Beaches
Thousands of dead fish washed up ashore in southwest Texas.
Few Rehab Centers for Addicted Teens Offer Recommended Medicine, U.S. Study Finds
Only 1 in 4 residential treatment centers for teens offers a recommended medicine for opioid addiction, according to a study that exposes an important gap in care.
